MENU
TMED
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

TMED stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
TMED
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for TMED with price predictions
Oct 01, 2026

TMED in downward trend: price dove below 50-day moving average on September 08, 2026

TMED moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend. In 3 of 4 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TMED as a result. In 12 of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for TMED turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In 11 of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

The 10-day moving average for TMED crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 1 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

The Aroon Indicator for TMED entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TMED's RSI Oscillator exited the oversold zone, 2 of 2 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMED advanced for three days, in 69 of 75 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

TMED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Gilead Sciences (NASDAQ:GILD), Intuitive Surgical (NASDAQ:ISRG), CVS HEALTH Corp (NYSE:CVS), McKesson Corp (NYSE:MCK), Elevance Health (NYSE:ELV), Boston Scientific Corp (NYSE:BSX), Humana (NYSE:HUM), Biogen (NASDAQ:BIIB).

Industry description

The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies. The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund is non-diversified.

Market Cap

The average market capitalization across the T. Rowe Price Health Care ETF (TMED) ETF is 62.32B. The market cap for tickers in the group ranges from 105.14M to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is BDTX at 105.14M.

High and low price notable news

The average weekly price growth across all stocks in the T. Rowe Price Health Care ETF (TMED) ETF was 192%. For the same ETF, the average monthly price growth was 152%, and the average quarterly price growth was 162%. KOD experienced the highest price growth at 196%, while BLLN experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the T. Rowe Price Health Care ETF (TMED) ETF was -3%. For the same stocks of the ETF, the average monthly volume growth was 32% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 64
Price Growth Rating: 53
SMR Rating: 77
Profit Risk Rating: 84
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
TMED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
100 EAST PRATT STREETBALTIMORE MD 21202
Phone
410-345-2000
Web
N/A
TMED in downward trend: price dove below 50-day moving average on September 08, 2026